Stay updated on HMPL-306 in IDH Mutant Myeloid Leukemia Clinical Trial
Sign up to get notified when there's something new on the HMPL-306 in IDH Mutant Myeloid Leukemia Clinical Trial page.

Latest updates to the HMPL-306 in IDH Mutant Myeloid Leukemia Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA minor site-wide revision tag v3.4.2 was added and the earlier revision notice v3.4.1 was removed, with no impact on the trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedSite-wide updates include a government funding notice and a v3.4.1 revision; these do not affect the study data, eligibility criteria, or results on this page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedUI and labeling tweaks were implemented, including showing the glossary, capitalization changes (Last Update Submitted that Met QC Criteria; No FEAR Act Data), and a new Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 has been added and Revision: v3.3.3 has been removed. This update appears to be a site maintenance/versioning change with no changes to study content.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations section updated: Beijing Municipality is now listed as a separate location under Locations, and the previous label 'Beijing Municipality Locations' was removed.SummaryDifference0.2%

- Check92 days agoChange DetectedMinor copy updates were made: a note clarifies that publications are automatically filled from PubMed and the page revision was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to HMPL-306 in IDH Mutant Myeloid Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HMPL-306 in IDH Mutant Myeloid Leukemia Clinical Trial page.